References
- Liljas B. How to calculate indirect costs in economic evaluations. PharmacoEconomics 13,1–7 (1998).
- Crystal-Peters J, Crown W, Goetzel R eta]. The cost of productivity losses associated with allergic rhinitis. Am. j Manag. Cate 6, 373–378 (2000).
- Rothermich E, Pathak D. Productivity cost controversies in cost-effectiveness analysis: review and research agenda. Clin. Thet: 21, 255–267 (1999).
- Weisbrod B. The valuation of human capital.J. Pol. Econ. 69,425–436 (1961).
- •Provides a general explanation of the human capital approach.
- Koopmanschap M, Rutten F. The impact of indirect costs on outcomes of health care programs. Health Econ. 3,385–393 (1994).
- Luce B, Manning W Siegel J, Lipscomb J. Estimating costs in cost-effectiveness analysis. In: Cast—effectivene s in Health and medicine. Gold M, Siegel J, Russell L et a/ (Eds). Oxford University Press, NY, USA (1996).
- Koopmanschap M, Rutten F. Indirect costs in economic studies: confronting the confusion. PhatmacoEconomics 4,446–454 (1993).
- Koopmanschap M, Rutten F. A practical guide for calculating indirect costs of disease. PhalmacoEconomics 10,460–466 (1996).
- •Provides a general explanation of the friction costing approach.
- Johannesson M, Karlsson G. The friction cost method: a comment. j Health Econ. 16,249–255 (1997).
- Koopmanschap M, Rutten F, van Inevald B, van Roijen L. Reply to Johanneson's and Karlsson's comment. j Health Econ.16, 257–259 (1997).
- Brouwer W, Koopmanschap M, Rutten E Patient and informal caregiver time in cost-effectiveness analysis: a response to the recommendations of the Washington panel. Int.j Tech. Assess. Health Cam 14,505–513 (1998).
- Brouwer W, Koopmanschap M, Rutten E Productivity costs measurement through quality of life? A response to the recommendations of the Washington panel. Health Econ. 6,253–259 (1997).
- Evans C, Crawford B. Data collection methods in prospective economic evaluations: how accurate are the results? Value Health 3,277–286 (2000).
- •Reviews the potential problems with using self-reported data in economic evaluations.
- Evans C, Crawford B. Patient self reports in harmacoeconomic studies: their use and impact on study validity. PharmacoEconomics 15,241–256 (1999).
- Evans C, Crawford B. Direct medical costing for economic evaluations: methodologies and impact on study validity. Drug Info. 34,173–184 (2000).
- Elixhauser A, Halpern M, Schmier J, Luce B. Health care CBA and CEA from 1991 to 1996: an updated bibliography. Merl Care 36, MS1—M59 (1998).
- Wimo A, Wetterholm A, Mastey V, Winblad B. Evaluation of healthcare resource utilization and caregiver time in anti-dementia drug trials — a quantitative battery. In: Health Economics of Dementia. Wimo A, Jönsson B, Karlsson G etal (Eds). John Wiley & Sons, NY, USA (1998).
- Thompson S, Wordsworth S. An annotated cost questionnaire for completion by patients. HERUDiscussion Paper No. (03/ 01).
- Scientific Advisory Committee of the Medical Outcomes Trust. Medical Outcomes Trust bulletin. 3(4), 1–4 (1995).
- Fayers P, Machin D. Quality of Life: Assessment, Analysis and Interpmtation. John Wiley and Sons, NY, USA (2000).
- Hays R, Anderson R, Revecki D. Psychometric Evaluation and Interpmtation of Health Related Quality of Life Data. Rapid Communications of Oxford Ltd., Oxford, UK (1995).
- Anderson RT, Aaronson NK, Bullinger M, McBee WL. a review of the progress towards developing health-related quality-of-life instruments for international clinical studies and outcomes research. PharmacoEconomics 10, 336–355 (1996).
- Coons S, Rao S, Keininger D, Hays R. A comparative review of generic quality-of-life instruments. PhatmacoEconomics 17, 13–36 (2000).
- Pollard W Bobbitt R, Bergner M eta] The sickness impact profile: reliability of a health status measure. Merl Cate 14, 146–155 (1976).
- McDowell J, Newell C. Measuring Health: a Guide to Rating Scales and Questionnaims. Second Edition. Oxford University Press, NY, USA (1996).
- Jette A, Davies A, Cleary P etal The functional status questionnaire: reliability and validity when used in primary care. Gen. Intern. Merl 1,143–149(1986).
- Shikar R, Rentz AM, Halpern MT, Khan ZM. The health and work questionnaire (HWQ): an instrument for assessing workplace productivity in relation to worker health. Value Health 4,181 (2001).
- Croog S, Sudilovsky A, Levince S, Testa M. Work performance, absenteeism and antihypertensive medications. Hypertension. 5 (Suppl. 1), S47—S54 (1987).
- Reilly M, Zbrozek A, Dukes E. The validity and reproducibility of a work productivity and activity impairment instrument. PhatmacoEconomics 4,353–365 (1993).
- Van Roijen L, Essink-Bot M, Koopmanschap M eta]. Labor and health status in economic evaluation of health care: the health and labor questionnaire. Intl .1. Tech. Assess. in Health Cam 12 (3), 405–415 (1996).
- Hakkaart-van Roijen L, Essink-Bot M. Manual Health and Labour Questionnaire. Rotterdam: Institute for Medical Technology Assessment. (2000).
- Endicott J, Nee J. Endicott Work Productivity Scale (EWPS): a new measure to assess treatment effects. Psycho. Bull. 33(1), 13–16 (1997).
- Lerner D, Amick B, Rogers W eta]. The work limitations questionnaire. Med. Cam 39(1), 72–85 (2001).
- Lerner D, Amick B, Lee J eta]. Relationship of employee-reported work limitations to work productivity. Merl Cam 41,649–659 (2003).
- •Reports on the criterion validity of the Work Limitations Questionnaire.
- Kessler R, Barber C, Beck A et al. The World Health Organization health and work performance questionnaire. Occupational Environ. Merl 45 (2), (2003) .
- •Reports on the validity of the Health gz Work Performance Questionnaire.
- Koopman C, Pelletier KR, Murray JF eta]. Stanford/American Health Association Presenteeism Scale: Linking health and productivity. I Occupational Environ. Merl 44(1), 1–7 (2002).
- Davies G, Santanello N, Gerth W eta]. Validation of a migraine work and productivity loss questionnaire for use in migraine studies. Cephalagia 19,497–502 (1999).
- Lerner D, Amick B, Malspeis S eta] The migraine work and productivity loss questionnaire: concepts and design. Qua]. Life Res. 8(8), 699–710 (1999).
- Lerner D, Amick B, Malspeis S etal The angina-related limitations at work questionnaire. Qua]. Life Res. 7,23–32 (1998).
- Lerner D, Amick B, Rogers W etal. The work limitations questionnaire. Med. Cate 39(1), 72–85 (2001).
- Johns G. Absentee estimates by employees and managers: divergent perspectives and self-serving perceptions. I Applied Psych. 79(2), 229–239 (1994).
- Severens J, Mulder J, Laheij R, Verbeek A. Precision and accuracy in measuring absence from work as a basis for calculating productivity costs in the Netherlands. Soc. Sci. Med. 51,2439–2249 (2000).
- Revicki D, Irwin D, Reblando J eta]. The accuracy of self-reported disability days. Med. Cam 32(4), 401–404 (1994).
- Spector P Method variance as an artifact in self-reported affect and perceptions at work: myth or significant problem?' Applied By& 72(3), 438–443 (1987).
- Mark J. A brief history of productivity measurement. In:Handbook for Productivity Measurement and Improvement Christopher W, Thor C (Eds). Productivity Press, OR, USA (1993).
- Forte D. Measuring federal government productivity. In: Handbook for Productivity Measurement and Improvement Christopher W, Thor C (Eds). Productivity Press, OR, USA (1993).
- Soniat E, Raaum R. Government productivity measurement as an analytical tool. In: Handbook for Productivity Measuirment and Improvement. Christopher W, Thor C (Eds). Productivity Press, OR, USA (1993).
- Thomas B, Baron J. Evaluating knowledge worker productivity: literature review. USACERL Interim Report FF —94/27. US Army Construction Engineering research Laboratories. (1994).
- Osterhaus J, Gutterman D, Plachetka J. Healthcare resource and lost labour costs of migraine headache in the US. PharmacoEconomics 2 (1), 67–76 (1992) .
- Brouwer W Koopmanschap M, Rutten Productivity losses without absence: measurement validation and empirical evidence. Health Policy 48,13–27 (1999).
- Cockburn I, Bailit H, Berndt E, Finkelstein S. Loss of work productivity due to illness and medical treatment. j. Occupational Environ. Med. 41(11), 948–953 (1999).
- Dalton D, Mesch D. On the extent and reduction of avoidable absenteeism: an assessment of absence policy provisions. Applied Psych. 76(6), 810–817 (1991).
- Von Korff M, Stewert W Simon D eta]. Migraine and reduced work performance: a population based diary study. Neurology50, 1741–1745 (1998).
- Johannesson M. Avoiding double-counting in pharmacoeconomic studies. PharmacoEconomics 11(5), 385–388 (1997).
- Schulman E, Cady R, Henry D eta]. Effectiveness of sumatriptan in reducing productivity loss due to migraine: results of a randomized, double-blind, placebo-controlled clinical trial. Mayo Clinic Proc. 75(8), 782–789 (2000).
- Reilly M, Tanner L, Meltzer E. Work, classroom and activity impairment instruments: validation studies in allergic rhinitis. Clin. Drug Invest. 11(5), 278–288 (1996).
Websites
- www.med.harvard.edu/ncs/hpt (Accessed October 2003)